News Release

Questcor Receives "Recognition of Appreciation" Award from MS Views & News

HAYWARD, Calif., May 28, 2014 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) today announced that it has been honored with a "Recognition of Appreciation" Award from MS Views & News, Inc., a leading multiple sclerosis (MS) education, information and advocacy organization.

"We are very proud to recognize Questcor for its exemplary support in helping to provide services to the multiple sclerosis community," said Stuart Schlossman, President and founder of MS Views & News. "Because of Questcor's steadfast dedication to the not-for-profit community, MS Views and News is readily able to reach out to tens of thousands of people affected by multiple sclerosis, including their caregivers and healthcare providers."

Mr. Schlossman presented the award today to Questcor at a special reception held in conjunction with the Consortium of Multiple Sclerosis Centers Meeting & Exhibition being held at the Hilton Anatole in Dallas. Questcor vice presidents Fran Olson and Darlene Romine together accepted the award on behalf of the company.

"Questcor is honored to receive this recognition from MS Views & News," said Steve Cartt, Questcor's Chief Operating Officer. "We are committed to serving the needs of MS patients, their families and the healthcare providers who care for them. Our work together has helped bridge an information and awareness gap related to the care of patients suffering from MS relapses, an area of medicine that historically has received little attention. We look forward to continuing this important partnership in the future and furthering these important educational efforts for MS patients."

About Multiple Sclerosis:
Multiple sclerosis (MS) involves an immune-mediated process in which an abnormal response of the body's immune system is directed against the central nervous system (CNS), which is made up of the brain, spinal cord and optic nerves. The exact antigen — or target that the immune cells are sensitized to attack — remains unknown, which is why MS is considered by many experts to be "immune-mediated" rather than "autoimmune." Within the CNS, the immune system attacks myelin — the fatty substance that surrounds and insulates the nerve fibers — as well as the nerve fibers themselves. The damaged myelin forms scar tissue (sclerosis), which gives the disease its name. When any part of the myelin sheath or nerve fiber is damaged or destroyed, nerve impulses traveling to and from the brain and spinal cord are distorted or interrupted, producing a wide variety of symptoms.

About MS Views & News:
MS Views and News is dedicated to the global collection and distribution of information concerning multiple sclerosis. The organization provides educational MS information via the Internet using its website, blog, e-Newsletter, YouTube Channel and social media. For more information, please visit

About Questcor Pharmaceuticals
Questcor Pharmaceuticals, Inc. is a biopharmaceutical company focused on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. Questcor's specific areas of focus are in the fields of neurology, nephrology, pulmonology and rheumatology, and the company is currently supporting research efforts in a variety of conditions having significant unmet medical need. For more information about Questcor, please visit

SOURCE Questcor Pharmaceuticals, Inc.

News Provided by Acquire Media